Compare AMWD & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMWD | FLGT |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 803.2M | 697.3M |
| IPO Year | N/A | 2016 |
| Metric | AMWD | FLGT |
|---|---|---|
| Price | $55.36 | $28.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $64.50 | $28.33 |
| AVG Volume (30 Days) | 244.9K | ★ 398.3K |
| Earning Date | 11-25-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.25 | N/A |
| Revenue | ★ $1,595,658,000.00 | $315,549,000.00 |
| Revenue This Year | N/A | $16.84 |
| Revenue Next Year | $2.63 | $9.74 |
| P/E Ratio | $13.22 | ★ N/A |
| Revenue Growth | N/A | ★ 13.61 |
| 52 Week Low | $47.15 | $14.57 |
| 52 Week High | $92.44 | $31.04 |
| Indicator | AMWD | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 56.08 |
| Support Level | $53.01 | $28.04 |
| Resistance Level | $57.67 | $31.04 |
| Average True Range (ATR) | 2.26 | 0.95 |
| MACD | 1.06 | -0.32 |
| Stochastic Oscillator | 82.83 | 22.16 |
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.